GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ModivCare Inc (NAS:MODV) » Definitions » Peter Lynch Fair Value

ModivCare (ModivCare) Peter Lynch Fair Value : N/A (As of Apr. 26, 2024)


View and export this data going back to 2003. Start your Free Trial

What is ModivCare Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for ModivCare's Peter Lynch Fair Value or its related term are showing as below:


During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of ModivCare was 10.56. The lowest was 1.70. And the median was 3.61.


MODV's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.33
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


ModivCare Peter Lynch Fair Value Historical Data

The historical data trend for ModivCare's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ModivCare Peter Lynch Fair Value Chart

ModivCare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 31.42 51.19 8.50 -

ModivCare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.50 1.00 - - -

Competitive Comparison of ModivCare's Peter Lynch Fair Value

For the Medical Care Facilities subindustry, ModivCare's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ModivCare's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ModivCare's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where ModivCare's Price-to-Peter-Lynch-Fair-Value falls into.



ModivCare Peter Lynch Fair Value Calculation

ModivCare's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *3.92
=N/A

ModivCare's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.92.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


ModivCare  (NAS:MODV) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

ModivCare's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=23.56/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ModivCare Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of ModivCare's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


ModivCare (ModivCare) Business Description

Traded in Other Exchanges
Address
6900 Layton Avenue, 12th Floor, Denver, CO, USA, 80237
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.
Executives
Barbara Gutierrez officer: Chief Financial Officer 8950 E. LOWRY BLVD., DENVER CO 80230
L Heath Sampson officer: Chief Financial Officer C/O ADVANCED EMISSIONS SOLUTIONS, INC., 9135 S RIDGELINE BLVD STE 200, HIGHLANDS RANCH CO 80129
Coliseum Capital Management, Llc director, 10 percent owner 105 ROWAYTON AVENUE, ROWAYTON CT 06853
Henry Toledo officer: Chief People Officer 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Jessica Kral officer: Chief Information Officer 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Anne E, Bailey officer: President, Home Division 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Rebecca Orcutt officer: VP, Chief Accounting Officer 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Brett M. Hickman officer: Chief Commercial Officer 6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Ilias Simpson officer: President, Transportation 6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Jason E Anderson officer: President of ModivCare Home 6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Grover Wray officer: Chief Human Resources Officer DIGITALGLOBE, INC., 1300 WEST 120TH AVENUE, WESTMINSTER CO 80234
Daniel E Greenleaf director, officer: CEO and President C/O NABI BIO PHARMACEUTICALS, 5800 PARK OF COMMERCE BLVD., N.W., BOCA RATON FL 33487
Jonathan B Bush officer: SVP, GC and Secretary 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Kenneth Shepard officer: Vice President, CAO 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Stacy Saal director 4700 SOUTH SYRACUSE STREET, 4TH FLOOR, DENVER CO 80237